Full Text View
Tabular View
No Study Results Posted
Related Studies
Noradrenalin vs Terlipressin in Hepatorenal Syndrome
This study has been completed.
Study NCT00370253   Information provided by University of Turin, Italy
First Received: August 30, 2006   Last Updated: April 9, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hepatorenal Syndrome
Additional conditions recognized in this trial
Syndrome
More general conditions related to this trial
Digestive System Diseases
Disease
Kidney Diseases
Liver Diseases
Pathologic Processes
Urologic Diseases
Interventions listed in this trial
Terlipressin
Noradrenalin
Additional drug interventions recognized in this trial
Norepinephrine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-Agonists
Antihypertensive Agents
Autonomic Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sympathomimetics
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
University of Turin, Italy


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services